Please use this identifier to cite or link to this item:
|Title:||Thalidomide in Behçet's disease|
|Authors:||Shek, L.P.C. |
|Source:||Shek, L.P.C., Lim, D.L.C. (2002). Thalidomide in Behçet's disease. Biomedicine and Pharmacotherapy 56 (1) : 31-35. ScholarBank@NUS Repository. https://doi.org/10.1016/S0753-3322(01)00154-8|
|Abstract:||Behçet's disease is a chronic relapsing multisystem disease of unknown aetiology. It has a relapsing cyclical course, and is characterized by the triad of aphthous stomatitis, genital ulcerations and uveitis. There is familial and geographical clustering of cases, especially around the Mediterranean, the Middle East and East Asia. The condition is uncommon, but lesions sometimes are recalcitrant and can be debilitating to the affected individual. The treatment of Behçet's currently involves the use of steroids, immunomodulaters and immunosuppressives. Thalidomide has been used in cases of Behçet's disease with some success. This review will discuss Behçet's disease and the current information we have about using thalidomide for its treatment. © 2002 Éditions scientifiques et médicales Elsevier SAS.|
|Source Title:||Biomedicine and Pharmacotherapy|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 20, 2018
WEB OF SCIENCETM
checked on Nov 29, 2017
checked on Feb 23, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.